In patients with chronic spontaneous urticaria, biomarkers such as a positive chronic urticaria index and low blood histamine content may help predict poor response to omalizumab at 12 weeks.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/biomarkers-may-predict-omalizumab-response-urticaria-2025a1000y8c?src=rss
Author :
Publish date : 2025-12-08 04:55:00
Copyright for syndicated content belongs to the linked Source.
